Onyx Unveils Results for Myeloma, Raising Stakes in Rivalry With Millennium

Onyx Pharmaceuticals is betting that it can keep growing on the strength of a new cancer drug that’s supposed to compete with a blockbuster from Cambridge, Mass.-based Millennium.
Xconomy